CTRI/2022/09/045671
Not yet recruiting
Not Applicable
Clinical Study Of Recurrent Urinary tract infection( Tadiya Majari e Bol Mutwatir) and its management with unani medicines.
PG Dept of Moalejat General Medicine1 site in 1 country40 target enrollmentStarted: September 20, 2022Last updated:
Overview
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- PG Dept of Moalejat General Medicine
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- Depends on before and after treatment.
Overview
Brief Summary
In Recurrent Urinary tract infection (Rutis) usual prophylactic antibiotics regimens donot change the long term risk of occurrence.the aim of the study is to evaluate the efficacy of unani medicines in Rutis.In this Randomised Single arm study with a sample size of 40 patients and 6 weeks of treatment with some inclusion and exclusion criteria( mentioned in part 6).
The study will be conducted.
Study Design
- Study Type
- Interventional
- Allocation
- Coin toss, Lottery, toss of dice, shuffling cards etc
- Masking
- Participant Blinded
Eligibility Criteria
- Ages
- 18.00 Year(s) to 60.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •1.Recurrent uti with positive urine culture, 2.Patients with symptoms as follows a.Burning micturition b.Urgency, c.frequency of micturition d.Haematuria(Benign) e.Lower abdominal pain/supra pubic pain f.Fever with chills and rigor g.Nausea and vomitings 3.Patients with renal calculi.
Exclusion Criteria
- •1.Complicated UTI 2.Patients with pregnancy 3.Patients with BPH 4.Chronic infections like TB; Gonorrhea; Syphills 5.Diabetes Mellitus 6.Patients with congenital abnormalities like polycystic kidney; renal agenesis; renal hypoplasia ; uretrovesical junction obstruction.
Outcomes
Primary Outcomes
Depends on before and after treatment.
Time Frame: Cure of the disease,relief in symptoms
Treatment will be given for the duration of 6 weeks
Time Frame: Cure of the disease,relief in symptoms
Secondary Outcomes
- Depends on before and after treatment(1.Changes in urine culture and sensitivity i.e negative culture 2.Cure of the disease, relief in symptoms)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 3
D Mannose in Recurrent Urinary Tract InfectionsRecurrent Urinary Tract InfectionNCT01808755Fondazione IRCCS Policlinico San Matteo di Pavia60
Not yet recruiting
Not Applicable
Recurrent Urinary tract infection (rUTI)Health Condition 1: N390- Urinary tract infection, site notspecifiedCTRI/2022/09/045671PG Dept of Moalejat General Medicine
Not yet recruiting
Phase 3
Can recurrent UTIs in post-menopausal women be prevented with aspirin?ACTRN12616000410459Prof Damon Eisen172
Terminated
Phase 4
Preventing Recurrent Urinary Tract Infections With α-D-mannoseUrinary Tract InfectionsNCT03497598Kantonsspital Aarau15
Completed
Not Applicable
Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitirinary tract infections (UTIs)Urological and Genital DiseasesOther disorders of urinary systemISRCTN76354426Magna Graecia University (Italy)60